{"id":80612,"date":"2021-08-26T07:21:25","date_gmt":"2021-08-26T11:21:25","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=80612"},"modified":"2021-08-26T07:40:28","modified_gmt":"2021-08-26T11:40:28","slug":"these-are-the-big-pharma-trojan-horses-who-just-betrayed-the-american-people-big-time","status":"publish","type":"post","link":"https:\/\/stateofthenation.co\/?p=80612","title":{"rendered":"<b>These are the treacherous <i>Big Pharma<\/i> insiders who just betrayed the American people&#8212;BIG TIME ! ! !<\/b>"},"content":{"rendered":"<h1 style=\"text-align: center;\"><strong>Duty to Warn<\/strong><\/h1>\n<h1>The Suspicious Roster of the FDA&#8217;s Advisory Committee that Voted on the Pfizer Vaccine<\/h1>\n<p><!--more--><\/p>\n<p>The Roster of the \u201cVaccines and Related Biological Products Advisory Committee\u201d that Voted on the Recent FDA\/Pfizer Vaccine Decision that was Announced on August 24, 2021<\/p>\n<p><strong>Collated by Gary G. Kohls, MD\u00a0<\/strong><\/p>\n<p><strong>Note: I boldened words and phrases in the brief bios below to indicate what to me represented possible Conflicts of Interest that perhaps should have disqualified the member from participating in the Pfizer vote<\/strong><\/p>\n<p><strong>Also note the following excerpt from the FDA\u2019s 13-page \u201capproval letter\u201d (dated August 23, 2120) says (on page 12) <\/strong><\/p>\n<p><a href=\"https:\/\/www.armstrongeconomics.com\/wp-content\/uploads\/2021\/08\/FDA-Letter-Final_Pfizer-LOA-to-issue-with-BLA-approval-08.23.21_v2.pdf\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.armstrongeconomics.com\/wp-content\/uploads\/2021\/08\/FDA-Letter-Final_Pfizer-LOA-to-issue-with-BLA-approval-08.23.21_v2.pdf&amp;source=gmail&amp;ust=1630062985554000&amp;usg=AFQjCNGJvxl4Lf7Yv31XvUokNnaTL5osXA\">https:\/\/www.armstrongeconomics.com\/wp-content\/uploads\/2021\/08\/FDA-Letter-Final_Pfizer-LOA-to-issue-with-BLA-approval-08.23.21_v2.pdf<\/a><\/p>\n<p><strong><em>\u201c<\/em><\/strong><strong><em>This product has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to prevent Coronavirus <\/em><\/strong><strong><em>Disease 2019 (COVID-19) for use in individuals 12 years of age and older; and <\/em><\/strong><\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong><em> The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency <\/em><\/strong><strong><em>use of the medical product under Section 564(b)(1) of the FD&amp;C Act unless the declaration is terminated or authorization revoked sooner.<\/em><\/strong><\/li>\n<\/ul>\n<p><strong>_______________________________________________________________________________________________________________________________<\/strong><\/p>\n<p><strong>Roster of the Vaccines and Related Biological Products Advisory Committee<\/strong><\/p>\n<p><a href=\"https:\/\/www.fda.gov\/advisory-committees\/vaccines-and-related-biological-products-advisory-committee\/roster-vaccines-and-related-biological-products-advisory-committee\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/advisory-committees\/vaccines-and-related-biological-products-advisory-committee\/roster-vaccines-and-related-biological-products-advisory-committee&amp;source=gmail&amp;ust=1630062985554000&amp;usg=AFQjCNFJnCSZcqeSjtMV42pSaUF67ozcIA\">https:\/\/www.fda.gov\/advisory-committees\/vaccines-and-related-biological-products-advisory-committee\/roster-vaccines-and-related-biological-products-advisory-committee<\/a><\/p>\n<p><a href=\"https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-membership\/applying-membership-fda-advisory-committees\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-membership\/applying-membership-fda-advisory-committees&amp;source=gmail&amp;ust=1630062985554000&amp;usg=AFQjCNFfADF38p7I08t0fu9MHW6ELNkzeA\"><strong>Applying for Membership on FDA Advisory Committees<\/strong><\/a><\/p>\n<p>As part of the Food and Drug Administration&#8217;s (FDA&#8217;s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.<\/p>\n<p><strong>Current Number of Vacancies: 1<\/strong><\/p>\n<p>Note, one or more vacancies may be in the nomination process or a final appointment may have been made.<\/p>\n<p><strong>Chair<br \/>\n<a href=\"https:\/\/www.fda.gov\/media\/98930\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/98930\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNFbnwqVU6yW0hAfGsnHcvsSADMi3g\">Hana El Sahly, M.D.<\/a><\/strong><br \/>\nExpertise: Vaccines, Infectious Diseases Term: 06\/21\/2019-01\/31\/2022<br \/>\nProfessor Department of Molecular Virology and Microbiology<br \/>\nDepartment of Medicine Section of Infectious Diseases Baylor College of Medicine Houston, TX 77030<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/135870\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/135870\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNG8HpDTZBxT_DjY9B3GNadIK4Uyjg\"><strong>Paula Annunziato, M.D.<\/strong>\u00a0***<\/a><br \/>\nExpertise: <strong>Industry Representative<\/strong> Term: 02\/01\/2020-01\/31\/2024<br \/>\n<strong>Vice President and Therapeutic Area Head, Vaccines Clinical Research, MERCK<\/strong>, North Wales, PA 19454<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/137429\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/137429\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNF5iMBS_DB-tNXRsuJbRo5qRvMbdg\"><strong>Archana Chatterjee, M.D., Ph.D.<\/strong><\/a><br \/>\nExpertise: <strong>Pediatrics<\/strong>, Infectious Diseases Term: 06\/21\/2019-01\/31\/2023<br \/>\nDean Chicago Medical School Vice President for Medical Affairs Rosalind Franklin University of Medicine and Science North Chicago, IL 60064<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/136851\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/136851\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNE4iO2bWcXB1IntvUiicUrL1_HbQg\"><strong>CAPT Amanda Cohn, M.D.<\/strong><\/a><br \/>\nExpertise: <strong>Pediatrics<\/strong>, Vaccines Term: 02\/01\/2020-01\/31\/2024<br \/>\n<strong>Chief Medical Officer National Center for Immunizations<\/strong> and Respiratory Diseases Centers for Disease Control and Prevention Atlanta, GA 30333<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/137165\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/137165\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNFvlg-L3YRsvGmCcavb155ngtpmyw\"><strong>Hayley Gans, M.D.<\/strong><\/a><br \/>\nExpertise: <strong>Pediatrics,<\/strong> Infectious Diseases Term: 06\/21\/2019-01\/31\/2023<br \/>\n<strong>Professor of Pediatrics<\/strong> Department of Pediatrics Stanford University Medical Center Stanford, CA 94305<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/98924\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/98924\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNFqaZJiDS_tqeWrzsxM2zaC93j0Pg\"><strong>Holly Janes, Ph.D.<\/strong><\/a><br \/>\nExpertise: Biostatistics Term: 02\/01\/2020-01\/31\/2023<br \/>\n<strong>Professor Fred Hutchinson Cancer Research Center Vaccine and Infectious Disease Division<\/strong>, Division of Public Health Sciences Seattle, WA 98109<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/117729\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117729\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNEX8-NVytmFhuoTMwbjV3mewkKbFg\"><strong>Michael Kurilla, M.D., Ph.D.<\/strong><\/a><br \/>\nExpertise: Infectious Diseases, Pathology Term: 08\/06\/2018-01\/31\/2022<br \/>\nDirector, Division of Clinical Innovation National Center for Advancing Translation Sciences National Institutes of Health Bethesda, MD 20852<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/128759\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/128759\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNFAOZ4-xUi5Z0chXZCLvH5xK7vjmQ\"><strong>Myron Levine, M.D., D.T.P.H., F.A.A.P<\/strong><\/a><br \/>\nExpertise: Infectious Diseases Term: 05\/09\/2018-01\/31\/2022<br \/>\nSimon &amp; Bessie Grollman Distinguished <strong>Professor Associate Dean for Global Health Vaccinology and Infectious Diseases Center for Vaccine Development<\/strong> University of Maryland School of Medicine Baltimore, MD 21201<\/p>\n<ol>\n<li><a href=\"https:\/\/www.fda.gov\/media\/117728\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117728\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNGKUH-Z_gs46A6dWMXHEtrHnbUsWw\"><strong> Cody Meissner, M.D.<\/strong><\/a><br \/>\nExpertise: Infectious Diseases Term: 08\/06\/2018-01\/31\/2022<br \/>\n<strong>Professor of Pediatrics<\/strong> Tufts University School of Medicine Director, Pediatric Infectious Disease Tufts Medical Center Boston, MA 02111<\/li>\n<\/ol>\n<p><strong><a href=\"https:\/\/www.fda.gov\/media\/117731\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117731\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNGD6QwWtFm6X-yLM5shOPXJFUndog\">Paul Offit, M.D.<\/a><\/strong><br \/>\nExpertise: Infectious Diseases Term: 02\/01\/2018-01\/31\/2022<br \/>\n<strong>Professor of Pediatrics<\/strong> Division of Infectious Diseases The Children\u2019s Hospital of Philadelphia Philadelphia, PA 19104<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/136854\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/136854\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNFu0blCV1SiVAorGnOlO9x0Mp6Nmg\"><strong>Steven Pergam, M.D.<\/strong><\/a><br \/>\nExpertise: Infectious Diseases Term: 02\/01\/2020-01\/31\/2024<br \/>\nMedical Director Infection Prevention <strong>Seattle Cancer Care Alliance<\/strong> Seattle, WA 98109<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/117726\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117726\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNH3o1eq4G1zamU6pSC_yKV2N86e7w\"><strong>Andrea Shane, M.D., M.P.H., M.Sc.<\/strong><\/a><br \/>\nExpertise: <strong>Pediatric<\/strong> &amp; Infectious Diseases Term: 02\/01\/2018-01\/31\/2022<br \/>\n<strong>Professor of Pediatrics<\/strong> Director Division of Pediatric Infectious Diseases Emory University School of Medicine Atlanta, GA 30322<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/117732\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117732\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNFooiQHVq3PEiZngDIM7TwJl1HiYQ\"><strong>Paul Spearman, M.D.<\/strong><\/a><br \/>\nExpertise: <strong>Pediatric <\/strong>&amp; Infectious Diseases Term: 05\/09\/2018-01\/31\/2022<br \/>\nDirector, Division of Infectious Diseases <strong>Albert B. Sabin Chair in Pediatric Infectious Diseases<\/strong> Cincinnati Children\u2019s Hospital Medical Center <strong>Professor, Department of Pediatrics<\/strong> University of Cincinnati School of Medicine Cincinnati, OH 45229<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/117727\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117727\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNFbqPxZGB2cT99uBvR4DZW5y0gYSw\"><strong>Geeta K. Swamy, M.D.<\/strong><\/a><br \/>\nExpertise: Infectious Diseases Term: 08\/06\/2018-01\/31\/2022<br \/>\nSenior Associate Dean Vice Chair for Research &amp; Faculty Development Associate Professor, ObGyn Department of Obstetrics &amp; Gynecology Division of Maternal-Fetal Medicine Duke University Durham, NC 27710<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/135869\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/135869\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNG6HNii_FLxq6ox5V3vPo2mv02h3A\"><strong>Gregg Sylvester, M.D., M.P.H.\u00a0<\/strong>+<\/a><br \/>\nExpertise: Alternate <strong>Industry Representative<\/strong> Term: 02\/01\/2020-01\/31\/2024<br \/>\nVice President Medical Affairs <strong>SEQIRUS INC.<\/strong> Summit, NJ 07901<\/p>\n<p>**Consumer Representative<br \/>\n***Industry Representative<br \/>\n+ Alternate Industry Representative<\/p>\n<p><strong>DIRECTOR<br \/>\nPrabhakara Atreya, Ph.D.<\/strong><br \/>\nDivision of Scientific Advisors &amp; Consultants Center for Biologics Evaluation &amp; Research Food and Drug Administration Silver Spring, MD 20993<u><a href=\"mailto:CBERVRBPAC@fda.hhs.gov\">CBERVRBPAC@fda.hhs.gov<\/a><\/u><\/p>\n<p><strong>DESIGNATED FEDERAL OFFICER<\/strong><br \/>\n<strong>Kathleen Hayes, M.P.H.<\/strong><br \/>\nDivision of Scientific Advisors &amp; Consultants Center for Biologics Evaluation &amp; Research Food and Drug Administration Silver Spring, MD 20993 <u><a href=\"mailto:CBERVRBPAC@fda.hhs.gov\">CBERVRBPAC@fda.hhs.gov<\/a><\/u><\/p>\n<p><strong>COMMITTEE MANAGEMENT SPECIALIST<br \/>\nMonique Hill, M.H.A.<\/strong><br \/>\nDivision of Scientific Advisors &amp; Consultants Center for Biologics Evaluation &amp; Research Food and Drug Administration Silver Spring, MD 20993 <a href=\"mailto:CBERVRBPAC@fda.hhs.gov\">CBERVRBPAC@fda.hhs.gov<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><a href=\"https:\/\/www.fda.gov\/advisory-committees\/vaccines-and-related-biological-products-advisory-committee\/roster-vaccines-and-related-biological-products-advisory-committee\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/advisory-committees\/vaccines-and-related-biological-products-advisory-committee\/roster-vaccines-and-related-biological-products-advisory-committee&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNEEkx6NNXbcPwVDpxd37_8XtJMprg\">https:\/\/www.fda.gov\/advisory-committees\/vaccines-and-related-biological-products-advisory-committee\/roster-vaccines-and-related-biological-products-advisory-committee<\/a><\/p>\n<p>As part of the Food and Drug Administration&#8217;s (FDA&#8217;s) ongoing efforts to recruit qualified experts with <strong>minimal conflicts of interest,<\/strong> who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.<\/p>\n<p><strong>Chair<br \/>\n<a href=\"https:\/\/www.fda.gov\/media\/98930\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/98930\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNFbnwqVU6yW0hAfGsnHcvsSADMi3g\">Hana El Sahly, M.D.<\/a><\/strong><br \/>\nExpertise: Vaccines, Infectious Diseases Term: 06\/21\/2019-01\/31\/2022<br \/>\nProfessor Department of Molecular Virology and Microbiology<br \/>\nDepartment of Medicine Section of Infectious Diseases Baylor College of Medicine Houston, TX 77030<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/135870\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/135870\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNG8HpDTZBxT_DjY9B3GNadIK4Uyjg\"><strong>Paula Annunziato, M.D.<\/strong>\u00a0***<\/a><br \/>\nExpertise: <strong>Industry Representative<\/strong> Term: 02\/01\/2020-01\/31\/2024<br \/>\n<strong>Vice President and Therapeutic Area Head, Vaccines Clinical Research, MERCK<\/strong>, North Wales, PA 19454<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/137429\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/137429\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNF5iMBS_DB-tNXRsuJbRo5qRvMbdg\"><strong>Archana Chatterjee, M.D., Ph.D.<\/strong><\/a><br \/>\nExpertise: <strong>Pediatrics<\/strong>, Infectious Diseases Term: 06\/21\/2019-01\/31\/2023<br \/>\nDean Chicago Medical School Vice President for Medical Affairs Rosalind Franklin University of Medicine and Science North Chicago, IL 60064<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/136851\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/136851\/download&amp;source=gmail&amp;ust=1630062985555000&amp;usg=AFQjCNE4iO2bWcXB1IntvUiicUrL1_HbQg\"><strong>CAPT Amanda Cohn, M.D.<\/strong><\/a><br \/>\nExpertise: <strong>Pediatrics<\/strong>, Vaccines Term: 02\/01\/2020-01\/31\/2024<br \/>\n<strong>Chief Medical Officer National Center for Immunizations<\/strong> and Respiratory Diseases Centers for Disease Control and Prevention Atlanta, GA 30333<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/137165\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/137165\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNHQdr2Kegcg04dat1v7xHn52y5Mag\"><strong>Hayley Gans, M.D.<\/strong><\/a><br \/>\nExpertise: <strong>Pediatrics,<\/strong> Infectious Diseases Term: 06\/21\/2019-01\/31\/2023<br \/>\n<strong>Professor of Pediatrics<\/strong> Department of Pediatrics Stanford University Medical Center Stanford, CA 94305<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/98924\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/98924\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNFgHP7T4aVYoDRQbIy7JgZ1RC3S0Q\"><strong>Holly Janes, Ph.D.<\/strong><\/a><br \/>\nExpertise: Biostatistics Term: 02\/01\/2020-01\/31\/2023<br \/>\n<strong>Professor Fred Hutchinson Cancer Research Center Vaccine and Infectious Disease Division<\/strong>, Division of Public Health Sciences Seattle, WA 98109<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/117729\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117729\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNG_c3dttCI9q1kclM54gNcEjR5OLQ\"><strong>Michael Kurilla, M.D., Ph.D.<\/strong><\/a><br \/>\nExpertise: Infectious Diseases, Pathology Term: 08\/06\/2018-01\/31\/2022<br \/>\nDirector, Division of Clinical Innovation National Center for Advancing Translation Sciences National Institutes of Health Bethesda, MD 20852<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/128759\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/128759\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNFfsd9jR7JblDLwqNv7uSgIjaDfaA\"><strong>Myron Levine, M.D., D.T.P.H., F.A.A.P<\/strong><\/a><br \/>\nExpertise: Infectious Diseases Term: 05\/09\/2018-01\/31\/2022<br \/>\nSimon &amp; Bessie Grollman Distinguished <strong>Professor Associate Dean for Global Health Vaccinology and Infectious Diseases Center for Vaccine Development<\/strong> University of Maryland School of Medicine Baltimore, MD 21201<\/p>\n<ol>\n<li><a href=\"https:\/\/www.fda.gov\/media\/117728\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117728\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNGPMDGykJQhTuPqmWGv3jElqJ6f_Q\"><strong> Cody Meissner, M.D.<\/strong><\/a><br \/>\nExpertise: Infectious Diseases Term: 08\/06\/2018-01\/31\/2022<br \/>\n<strong>Professor of Pediatrics<\/strong> Tufts University School of Medicine Director, Pediatric Infectious Disease Tufts Medical Center Boston, MA 02111<\/li>\n<\/ol>\n<p><strong><a href=\"https:\/\/www.fda.gov\/media\/117731\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117731\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNGB-4WGe3Q8RUrPCJImVesswI2jQA\">Paul Offit, M.D.<\/a><\/strong><br \/>\nExpertise: Infectious Diseases Term: 02\/01\/2018-01\/31\/2022<br \/>\n<strong>Professor of Pediatrics<\/strong> Division of Infectious Diseases The Children\u2019s Hospital of Philadelphia Philadelphia, PA 19104<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/136854\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/136854\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNFANUA4GJLs8mMIN7YKImXXYGNorg\"><strong>Steven Pergam, M.D.<\/strong><\/a><br \/>\nExpertise: Infectious Diseases Term: 02\/01\/2020-01\/31\/2024<br \/>\nMedical Director Infection Prevention <strong>Seattle Cancer Care Alliance<\/strong> Seattle, WA 98109<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/117726\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117726\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNHDCDFepQaKMWPqyj7keQufM23Ifg\"><strong>Andrea Shane, M.D., M.P.H., M.Sc.<\/strong><\/a><br \/>\nExpertise: <strong>Pediatric<\/strong> &amp; Infectious Diseases Term: 02\/01\/2018-01\/31\/2022<br \/>\n<strong>Professor of Pediatrics<\/strong> Director Division of Pediatric Infectious Diseases Emory University School of Medicine Atlanta, GA 30322<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/117732\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117732\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNGGfkeknqv5Hk0-upXN6TX6C8FE0w\"><strong>Paul Spearman, M.D.<\/strong><\/a><br \/>\nExpertise: <strong>Pediatric <\/strong>&amp; Infectious Diseases Term: 05\/09\/2018-01\/31\/2022<br \/>\nDirector, Division of Infectious Diseases <strong>Albert B. Sabin Chair in Pediatric Infectious Diseases<\/strong> Cincinnati Children\u2019s Hospital Medical Center <strong>Professor, Department of Pediatrics<\/strong> University of Cincinnati School of Medicine Cincinnati, OH 45229<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/117727\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117727\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNH-M-vyz0lFgUhl87VPGX34bue_MA\"><strong>Geeta K. Swamy, M.D.<\/strong><\/a><br \/>\nExpertise: Infectious Diseases Term: 08\/06\/2018-01\/31\/2022<br \/>\nSenior Associate Dean Vice Chair for Research &amp; Faculty Development Associate Professor, ObGyn Department of Obstetrics &amp; Gynecology Division of Maternal-Fetal Medicine Duke University Durham, NC 27710<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/media\/135869\/download\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/135869\/download&amp;source=gmail&amp;ust=1630062985556000&amp;usg=AFQjCNFhmnQL0NvSROQ7kD8C1iUIYislNw\"><strong>Gregg Sylvester, M.D., M.P.H.\u00a0<\/strong>+<\/a><br \/>\nExpertise: Alternate <strong>Industry Representative<\/strong> Term: 02\/01\/2020-01\/31\/2024<br \/>\nVice President Medical Affairs <strong>SEQIRUS INC.<\/strong> Summit, NJ 07901<\/p>\n<p>**Consumer Representative<br \/>\n***Industry Representative<br \/>\n+ Alternate Industry Representative<\/p>\n<p><strong>DIRECTOR<br \/>\nPrabhakara Atreya, Ph.D.<\/strong><br \/>\nDivision of Scientific Advisors &amp; Consultants Center for Biologics Evaluation &amp; Research Food and Drug Administration Silver Spring, MD 20993<u><a href=\"mailto:CBERVRBPAC@fda.hhs.gov\">CBERVRBPAC@fda.hhs.gov<\/a><\/u><\/p>\n<p><strong>DESIGNATED FEDERAL OFFICER<\/strong><br \/>\n<strong>Kathleen Hayes, M.P.H.<\/strong><br \/>\nDivision of Scientific Advisors &amp; Consultants Center for Biologics Evaluation &amp; Research Food and Drug Administration Silver Spring, MD 20993 <u><a href=\"mailto:CBERVRBPAC@fda.hhs.gov\">CBERVRBPAC@fda.hhs.gov<\/a><\/u><\/p>\n<p><strong>COMMITTEE MANAGEMENT SPECIALIST<br \/>\nMonique Hill, M.H.A.<\/strong><br \/>\nDivision of Scientific Advisors &amp; Consultants Center for Biologics Evaluation &amp; Research Food and Drug Administration Silver Spring, MD 20993 <a href=\"mailto:CBERVRBPAC@fda.hhs.gov\">CBERVRBPAC@fda.hhs.gov<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Duty to Warn The Suspicious Roster of the FDA&#8217;s Advisory Committee that Voted on the Pfizer Vaccine<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-80612","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/80612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=80612"}],"version-history":[{"count":0,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/80612\/revisions"}],"wp:attachment":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=80612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=80612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=80612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}